Mats Remberger

Recent publications by Mats Remberger

1. Prospective Double-Blind Randomized Study of Single Dose Bone Marrow-Derived Mesenchymal Stromal Cells versus Placebo for Steroid-Refractory Acute Graft-Versus-Host DiseaseTransfusion Medicine and Hemotherapy · Fri,
2. Allogeneic stem cell transplantation for acute myeloid leukaemia 2005–22Tidsskrift for Den norske legeforening · Tue,
3. Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG‐PTCy‐CSA for GVHD prophylaxisBritish Journal of Haematology · Thu,
4. Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationBritish Journal of Haematology · Sat,
5. Hospital at Home Following Allogeneic Hematopoietic Stem Cell Transplantation: An Economic AnalysisHealthcare · Tue,
6. Impact of Conditioning Intensity on Survival in Adult Patients (GVHD ProphylaxisEuropean Journal Of Haematology · Wed,
7. Exploring the impact of opioid use on outcomes in allogeneic hematopoietic stem cell transplantationPLoS ONE · Fri,
8. Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell TransplantationCancers · Fri,
9. Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factorseJHaem · Thu,
10. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyFrontiers in Immunology · Mon,